一、里昂证券调整海吉亚医疗目标价及评级里昂证券发布研报,对海吉亚医疗(06078)的未来表现进行分析。尽管将其目标价从17港元下调至15.9港元,但仍维持“跑赢大市”的投资评级。该行认为,展望2026年,公司主要的增长动力将来自非国家医保目录收入的扩张、现有医院利用率的提升以及通过降低负债率推动经营杠杆以重建利润率。二、盈警后业绩下滑或已触底虽然海吉亚医疗近期发布了盈警,但里昂证券认为其业绩下滑...
Source Link一、里昂证券调整海吉亚医疗目标价及评级里昂证券发布研报,对海吉亚医疗(06078)的未来表现进行分析。尽管将其目标价从17港元下调至15.9港元,但仍维持“跑赢大市”的投资评级。该行认为,展望2026年,公司主要的增长动力将来自非国家医保目录收入的扩张、现有医院利用率的提升以及通过降低负债率推动经营杠杆以重建利润率。二、盈警后业绩下滑或已触底虽然海吉亚医疗近期发布了盈警,但里昂证券认为其业绩下滑...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.